• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特征明确的转录谱表明骨髓基质细胞而非成骨细胞与多发性骨髓瘤骨病相关。

Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease.

机构信息

Dipartimento di Scienze Mediche, Università di Milano e U.O. Ematologia 1, Fondazione IRCCS Policlinico, Milan, Italy.

出版信息

Exp Hematol. 2010 Feb;38(2):141-53. doi: 10.1016/j.exphem.2009.11.009. Epub 2009 Dec 4.

DOI:10.1016/j.exphem.2009.11.009
PMID:19963035
Abstract

OBJECTIVE

Multiple myeloma (MM) is characterized by a high incidence of osteolytic bone lesions, which have been previously correlated with the gene expression profiles of MM cells. The aim of this study was to investigate the transcriptional patterns of cells in the bone microenvironment and their relationships with the presence of osteolysis in MM patients.

MATERIALS AND METHODS

Both mesenchymal (MSC) and osteoblastic (OB) cells were isolated directly from bone biopsies of MM patients and controls to perform gene expression profiling by microarrays and real-time polymerase chain reaction on selected bone-related genes.

RESULTS

We identified a series of upregulated and downregulated genes that were differentially expressed in the MSC cells of osteolytic and nonosteolytic patients. Comparison of the osteolytic and nonosteolytic samples also showed that the MSC cells and OB had distinct transcriptional patterns. No significantly modulated genes were found in the OBs of the osteolytic and nonosteolytic patients.

CONCLUSIONS

Our data suggest that the gene expression profiles of cells of the bone microenvironment are different in MM patients and controls, and that MSC cells, but not OBs, have a distinct transcriptional pattern associated with the occurrence of bone lesions in MM patients. These data support the idea that alterations in MSC cells may be involved in MM bone disease.

摘要

目的

多发性骨髓瘤(MM)的特征是溶骨性骨病变发生率高,此前已将其与 MM 细胞的基因表达谱相关联。本研究旨在研究骨微环境中细胞的转录模式及其与 MM 患者溶骨性的关系。

材料和方法

直接从 MM 患者和对照者的骨活检中分离间充质(MSC)和成骨细胞(OB),通过微阵列和实时聚合酶链反应对选定的与骨相关的基因进行基因表达谱分析。

结果

我们确定了一系列在溶骨性和非溶骨性患者的 MSC 细胞中差异表达的上调和下调基因。对溶骨性和非溶骨性样本的比较还表明,MSC 细胞和 OB 具有不同的转录模式。在溶骨性和非溶骨性患者的 OB 中未发现明显调节的基因。

结论

我们的数据表明,骨微环境中细胞的基因表达谱在 MM 患者和对照者中存在差异,并且 MSC 细胞而非 OB 具有与 MM 患者骨病变发生相关的独特转录模式。这些数据支持 MSC 细胞的改变可能与 MM 骨病有关的观点。

相似文献

1
Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease.特征明确的转录谱表明骨髓基质细胞而非成骨细胞与多发性骨髓瘤骨病相关。
Exp Hematol. 2010 Feb;38(2):141-53. doi: 10.1016/j.exphem.2009.11.009. Epub 2009 Dec 4.
2
Myeloma and Bone Disease.多发性骨髓瘤与骨病。
Curr Osteoporos Rep. 2017 Oct;15(5):483-498. doi: 10.1007/s11914-017-0397-5.
3
A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function.CCL3(MIP-1α)通过下调骨钙素和抑制成骨细胞功能在骨髓瘤骨病中发挥新作用。
Leukemia. 2011 Jul;25(7):1174-81. doi: 10.1038/leu.2011.43. Epub 2011 Mar 15.
4
An Evidence-Based Approach to Myeloma Bone Disease.骨髓瘤骨病的循证治疗方法
Curr Hematol Malig Rep. 2017 Apr;12(2):109-118. doi: 10.1007/s11899-017-0370-5.
5
CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions.CC趋化因子配体20/巨噬细胞炎性蛋白-3α和CC趋化因子受体6在与溶骨性骨病变相关的骨髓瘤微环境中过表达。
Cancer Res. 2008 Aug 15;68(16):6840-50. doi: 10.1158/0008-5472.CAN-08-0402.
6
The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.Wnt信号拮抗剂DKK1在多发性骨髓瘤溶骨性病变发展中的作用。
N Engl J Med. 2003 Dec 25;349(26):2483-94. doi: 10.1056/NEJMoa030847.
7
Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: a possible role for HGF in myeloma-associated osteolytic bone disease.肝细胞生长因子(HGF)诱导成骨细胞分泌白细胞介素-11:HGF在骨髓瘤相关溶骨性骨病中的可能作用。
Blood. 1999 Dec 1;94(11):3883-8.
8
Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.多发性骨髓瘤中骨重塑改变的生物学特性及药物干预的可能性
Dan Med Bull. 2011 May;58(5):B4277.
9
Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients.在多发性骨髓瘤患者中,骨成骨细胞和间充质基质细胞主要缺乏肿瘤特征。
Leukemia. 2010 Jul;24(7):1368-70. doi: 10.1038/leu.2010.96. Epub 2010 May 20.
10
Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells.骨髓瘤细胞诱导的骨重塑隔室破坏导致溶骨性病变和破骨细胞-骨髓瘤杂交细胞的产生。
Br J Haematol. 2010 Feb;148(4):551-61. doi: 10.1111/j.1365-2141.2009.07980.x. Epub 2009 Nov 16.

引用本文的文献

1
Chromosomal abnormalities of mesenchymal stromal cells in hematological malignancies.血液系统恶性肿瘤中间充质基质细胞的染色体异常。
Oncogene. 2025 Aug 14. doi: 10.1038/s41388-025-03528-4.
2
Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma.多发性骨髓瘤患者骨髓间充质干细胞的生物学和转录组学特征分析
Cancer Cell Int. 2024 Mar 27;24(1):116. doi: 10.1186/s12935-024-03308-2.
3
Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma.
意义未明的单克隆丙种球蛋白血症、冒烟型骨髓瘤和多发性骨髓瘤患者的基质改变。
Blood Adv. 2024 May 28;8(10):2575-2588. doi: 10.1182/bloodadvances.2023011632.
4
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers.骨髓基质细胞在血液系统恶性肿瘤骨髓微环境重塑中的作用。
Biomolecules. 2023 Nov 24;13(12):1701. doi: 10.3390/biom13121701.
5
Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling.多发性骨髓瘤中的炎性骨髓间充质干细胞:转录特征与体外建模
Cancers (Basel). 2023 Oct 26;15(21):5148. doi: 10.3390/cancers15215148.
6
Simultaneously Targeting Two Coupled Signalling Molecules in the Mesenchymal Stem Cell Support Efficiently Sensitises the Multiple Myeloma Cell Line H929 to Bortezomib.同时靶向骨髓基质干细胞中两种偶联信号分子可有效增敏多发性骨髓瘤细胞系 H929 对硼替佐米的敏感性。
Int J Mol Sci. 2023 May 2;24(9):8157. doi: 10.3390/ijms24098157.
7
Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again.单克隆丙种球蛋白病与骨髓微环境:从 bench 到 bedside 再回归 bench
Hematol Rep. 2023 Jan 9;15(1):23-49. doi: 10.3390/hematolrep15010004.
8
Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma.多发性骨髓瘤中骨髓间充质和成骨细胞的分子特征。
Int J Mol Sci. 2022 Dec 7;23(24):15448. doi: 10.3390/ijms232415448.
9
Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells.抑制多发性骨髓瘤相关间充质干细胞中的PI3K-AKT-mTOR信号传导可阻碍多发性骨髓瘤细胞的增殖。
Front Oncol. 2022 Jun 20;12:874325. doi: 10.3389/fonc.2022.874325. eCollection 2022.
10
Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma.多发性骨髓瘤中恶性浆细胞与肿瘤微环境之间的表观遗传串扰
Cancers (Basel). 2022 May 24;14(11):2597. doi: 10.3390/cancers14112597.